Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Genome-wide association analysis of young onset stroke identifies a locus on chromosome 10q25 near HABP2.
Stroke 47, 307-316 (2016)
BACKGROUND AND PURPOSE: Although a genetic contribution to ischemic stroke is well recognized, only a handful of stroke loci have been identified by large-scale genetic association studies to date. Hypothesizing that genetic effects might be stronger for early- versus late-onset stroke, we conducted a 2-stage meta-analysis of genome-wide association studies, focusing on stroke cases with an age of onset <60 years. METHODS: The discovery stage of our genome-wide association studies included 4505 cases and 21 968 controls of European, South-Asian, and African ancestry, drawn from 6 studies. In Stage 2, we selected the lead genetic variants at loci with association P<5×10(-6) and performed in silico association analyses in an independent sample of ≤1003 cases and 7745 controls. RESULTS: One stroke susceptibility locus at 10q25 reached genome-wide significance in the combined analysis of all samples from the discovery and follow-up stages (rs11196288; odds ratio =1.41; P=9.5×10(-9)). The associated locus is in an intergenic region between TCF7L2 and HABP2. In a further analysis in an independent sample, we found that 2 single nucleotide polymorphisms in high linkage disequilibrium with rs11196288 were significantly associated with total plasma factor VII-activating protease levels, a product of HABP2. CONCLUSIONS: HABP2, which encodes an extracellular serine protease involved in coagulation, fibrinolysis, and inflammatory pathways, may be a genetic susceptibility locus for early-onset stroke.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
5.787
2.311
26
36
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Factor Vii ; Genetics ; Genome-wide Analysis ; Ischemic Stroke ; Stroke; Vii-activating Protease; Antihypertensive Drug Therapies; Acute Ischemic-stroke; Factor-v-leiden; Causative Classification; Atherosclerotic Stroke; Atrial-fibrillation; Follow-up; Risk; Genetics
Sprache
Veröffentlichungsjahr
2016
HGF-Berichtsjahr
2016
ISSN (print) / ISBN
0039-2499
e-ISSN
1524-4628
Zeitschrift
Stroke
Quellenangaben
Band: 47,
Heft: 2,
Seiten: 307-316
Verlag
Lippincott Williams & Wilkins
Verlagsort
Philadelphia
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Genetic Epidemiology (IGE)
Institute of Epidemiology (EPI)
Institute of Epidemiology (EPI)
POF Topic(s)
30501 - Systemic Analysis of Genetic and Environmental Factors that Impact Health
30202 - Environmental Health
30202 - Environmental Health
Forschungsfeld(er)
Genetics and Epidemiology
PSP-Element(e)
G-504100-001
G-504091-004
G-504091-001
G-504000-006
G-504091-004
G-504091-001
G-504000-006
WOS ID
WOS:000377040200014
Scopus ID
84969389433
PubMed ID
26732560
Erfassungsdatum
2016-01-11